Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Delaware Medical Journal|June 17, 2005
Bisphosphonates, cancer, and osteonecrosis--a single practice experienceMichael J Guarino, Constance E Hill, Ketan PatelThe Oncologist|December 20, 2002
A dose-escalation study of weekly topotecan, cisplatin, and gemcitabine front-line therapy in patients with inoperable non-small cell lung cancerMichael J Guarino, Charles J Schneider, Stephen S Grubbs, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
Testosterone levels and quality of life in diverse male patients with cancers unrelated to androgensStewart B Fleishman, Hina Khan, Peter Homel, et al.The Oncologist|February 3, 2009
Dual inhibition of the epidermal growth factor receptor pathway with cetuximab and erlotinib: a phase I study in patients with advanced solid malignanciesMichael J Guarino, Charles J Schneider, Martha A Hosford, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept StudyMatthew H Taylor, Courtney B Betts, Lauren Maloney, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid TumorsAlexander N Starodub, Allyson J Ocean, Manish A Shah, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2017
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients with Chemorefractory Metastatic Colorectal CancerAxel Grothey, Jonathan R Strosberg, Lindsay A Renfro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2017
Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal CancerEfrat Dotan, Steven J Cohen, Alexander N Starodub, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancerNasser Altorki, Maureen E Lane, Thomas Bauer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2017
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab GovitecanRebecca Suk Heist, Michael J Guarino, Gregory Masters, et al.Pageof 2